Aptevo Therapeutics APVO
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 26.10 | 17 | -63.13 | -8 | -35.42 | 27 |
| 2025Q2 | 54.90 | 7 | -6 | -51.77 | 16 | |
| 2025Q1 | 417.60 | -1 | -6 | -53.55 | 8 | |
| 2024Q4 | 1551.60 | 5 | -137.59 | -6 | -41.07 | 16 |
| 2024Q3 | 2394.94 | 4 | -114.85 | -5 | -33.93 | 15 |
| 2024Q2 | 4075.92 | 4 | -111.36 | -6 | -36.15 | 15 |
| 2024Q1 | 62470.80 | 6 | -74.59 | -7 | -32.18 | 18 |
| 2023Q4 | 106080.48 | 12 | -43.82 | -6 | -22.72 | 25 |
| 2023Q3 | 193406.40 | 15 | -40.90 | -6 | -22.60 | 27 |
| 2023Q2 | 855676.80 | 16 | -40.23 | -8 | -24.88 | 29 |
| 2023Q1 | 1192672.80 | 23 | 13.45 | 3 | 8.02 | 35 |
| 2022Q4 | 1359705.60 | 18 | -27.52 | -5 | -14.09 | 34 |
| 2022Q3 | 1781683.20 | 16 | -39.39 | -8 | -21.69 | 32 |
| 2022Q2 | 2098166.40 | 23 | 28 | 66.70 | 39 | |
| 2022Q1 | 3440289.60 | -6 | -8 | -15.12 | 45 | |
| 2021Q4 | 4612449.61 | 1 | -147.44 | -6 | -10.40 | 57 |
| 2021Q3 | 9049075.21 | 7 | -66.09 | -7 | -10.33 | 64 |
| 2021Q2 | 13145774.42 | 14 | -65.06 | -8 | -11.31 | 71 |
| 2021Q1 | 17887161.63 | 11 | -53.55 | -7 | -11.87 | 69 |
| 2020Q4 | 21479832.03 | 17 | -75.05 | -7 | -15.51 | 54 |